Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
24.22
+0.17 (0.71%)
Jun 5, 2025, 10:23 AM - Market open
Cidara Therapeutics Employees
Cidara Therapeutics had 38 employees as of December 31, 2024. The number of employees decreased by 31 or -44.93% compared to the previous year.
Employees
38
Change (1Y)
-31
Growth (1Y)
-44.93%
Revenue / Employee
$7,947
Profits / Employee
-$4,815,289
Market Cap
314.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CDTX News
- 10 days ago - Cidara Therapeutics: All Stars Aligning In Favor Of CD388 - Seeking Alpha
- 21 days ago - Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025 - GlobeNewsWire
- 23 days ago - Cidara Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - Cidara Therapeutics, Inc. (CDTX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Cidara Therapeutics: Strong Buy On Imminent Data Readout For Lead Flu Candidate - Seeking Alpha
- 5 weeks ago - Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development - GlobeNewsWire
- 5 weeks ago - Cidara Therapeutics to Participate in The Citizens Life Sciences Conference - GlobeNewsWire